maradon 333 /
25 November 2016Americas

Novartis acquires Selexys Pharmaceuticals

Novartis has acquired Selexys Pharmaceuticals Corporation, a company specialising in the development of therapeutics in certain hematologic and inflammatory disorders.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at